Researchers investigated the use of artificial intelligence to evaluate skin lesions suspicious for melanoma in camera-based images as a potential decision-support tool.
For individuals with obesity, risk for skin cancer and melanoma significantly reduced with bariatric surgery.
This study sought to determine gender differences regarding melanoma survivors’ perceptions of partner support and comfort in performing skin self-examinations.
Overall survival at five years longer with nivolumab + ipilimumab, nivolumab alone versus ipilimumab.
Survival modestly improved compared with traditional surgery with wide margin excision.
Treatment-free survival could help capture additional perspective about the patient experience during immune checkpoint inhibitor therapy, a study concluded.
Regional variation considerable, with more than threefold variation between regions with highest, lowest use.
In the modern era of therapeutic agents, metastasectomy was still associated with improved survival outcomes for patients with stage IV melanoma.
A meta-analysis sought to determine if survival is improved with dual targeting of the MAPK pathway with BRAF and MEK inhibitors vs BRAF inhibition alone in patients with advanced melanoma.
The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech)
